Researchers are excited about Retatrutide , a innovative dual compound showing promising results in early trials for size loss . It works by targeting both pathways : GLP-1 and GIP, that , when engaged , assist control hunger and enhance metabolism . Early observations demonstrate noteworthy body management and possible improvements for individuals